Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Daxor Corp

DXR ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Financials · Closed End Funds ·

USA Micro Cap Analyst: BUY

Last Close

$10.11

▲ +0.00%

Market Cap $60.72M · Vol 1

Key Metrics

P/E Ratio

5.25

FWD: N/A

Market Cap

$60.72M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

-111.60%

YoY

RSI (14)

30.31

Momentum

Beta

0.20

vs Market

52W High

$15.00

32.60% below

52W Low

$8.58

17.90% above

Volume

Avg 580

P/B

1.63

Price-to-book

ROE

N/A

Return on equity

Free Float

49.91%

Public shares

Shariah Compliance8 STANDARDS

✗ Daxor Corp (DXR) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does DXR pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-2.98%

-10.53%

-19.79%

YTD

-31.46%

-4.71%

+5.42%

+8.48%

Financials & Valuation

TTM · Annual

Total Revenue	$26.69K
Net Income	$9.17M
Revenue Growth (YoY)	+204.08%
Gross Margin	92.58%
Operating Margin	89.01%
Net Profit Margin	88.86%
ROE	N/A
ROA · ROIC	22.19% · 22.29%

P/E Ratio	5.25
Forward P/E (FY1)	N/A
PEG Ratio	0.01
P/S	7.23
P/B	1.63
P/FCF	N/A
EPS Growth	-111.60%
Outstanding Shares	5.84M

Technical Indicators

50-Day SMA	$10.36
200-Day SMA	$11.51
RSI (14)	30.31
Beta	0.20
52-Week High	$15.00
52-Week Low	$8.58

Volume Today	1
Avg Daily Volume (30D)	580
Relative Volume	0.00x
Volatility (10D)	30.62
Volatility (30D)	58.42
Free Float	49.91%

Analyst Consensus

BUY

Current Price $10.11

Mean Target $23.00

52W Low$8.58 52W High$15.00

Current

Target

$8.58 $15.00

Current Analyst target

+127.50% upside potential · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S5QPC8

ISINUS2394671034

CountryUnited States of America

Sub-IndustryClosed End Funds

Earnings DateMay 15, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

Company Profile

Daxor Corporation is a diversified, closed-end management investment company. Its focus and operations are as a medical device manufacturing, company. It specializes in blood volume measurement technology focused on blood volume testing innovation. It markets the Blood Volume Analyzer (BVA)-100, the diagnostic blood test cleared by the FDA to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 65,000 tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. Its facility provides on-demand, next day blood volume analysis results. It has several ongoing trials in the areas of heart failure treatment with support from the NIH and is under contract developing analyzers to improve combat casualty care with the United States Department of Defense.